News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,688 Results
Type
Article (8019)
Company Profile (140)
Press Release (477528)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166761)
Career Advice (305)
Deals (25740)
Drug Delivery (7)
Drug Development (52879)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238247)
Policy (17923)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33162)
ALS (106)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (277)
Approvals (10397)
Artificial intelligence (326)
ASCO (159)
Autoimmune disease (216)
Automation (29)
Bankruptcy (263)
Best Places to Work (6963)
BIO (36)
Biologics (9)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (516)
Cancer (3720)
Cardiovascular disease (225)
Career advice (246)
Career pathing (1)
CAR-T (177)
CDMO (10)
Celiac Disease (1)
Cell therapy (483)
Cervical cancer (35)
Clinical research (47992)
Collaboration (1270)
Commercialization (3)
Compensation (1519)
Complete response letters (34)
COVID-19 (762)
CRISPR (64)
C-suite (790)
Cystic fibrosis (86)
Data (5808)
Denatured (4)
Depression (103)
Dermatology (67)
Diabetes (350)
Diagnostics (4202)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73742)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88050)
Executive appointments (711)
FDA (12449)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (24)
Funding (937)
Gene editing (126)
Generative AI (9)
Gene therapy (329)
GLP-1 (294)
Government (955)
Grass and pollen (2)
Guidances (281)
Healthcare (9380)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (101)
Immuno-oncology (61)
Indications (159)
Infectious disease (952)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (259)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (16)
Liver cancer (45)
Longevity (19)
Lung cancer (521)
Lymphoma (257)
Machine learning (27)
Management (3)
Manufacturing (554)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8674)
Medtech (8829)
Mergers & acquisitions (14402)
Metabolic disorders (718)
mRNA (60)
Multiple sclerosis (105)
NASH (4)
Neurodegenerative disease (224)
Neuropsychiatric disorders (40)
Neuroscience (1851)
NextGen: Class of 2026 (3153)
Non-profit (848)
Obesity (227)
Opinion (10)
Ovarian cancer (161)
Pain (177)
Pancreatic cancer (204)
Parkinson's disease (204)
Partnered (12)
Patents (490)
Patient recruitment (523)
Peanut (31)
People (41340)
Peptides (1)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15505)
Phase 2 (21423)
Phase 3 (14452)
Pipeline (7603)
Policy (18)
Postmarket research (1572)
Preclinical (6550)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (194)
Rare diseases (583)
Real estate (3024)
Recruiting (6)
Regulatory (14913)
Reports (23)
Research institute (585)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (89)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Supply chain (51)
Vaccines (332)
Venture capital (17)
Weight loss (74)
Women's health (83)
Date
Today (86)
Last 7 days (378)
Last 30 days (1479)
Last 365 days (19045)
2026 (13324)
2025 (19251)
2024 (22986)
2023 (26538)
2022 (34594)
2021 (37168)
2020 (33479)
2019 (23256)
2018 (17493)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21683)
2013 (18135)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (76)
Alaska (2)
Arizona (309)
Arkansas (11)
Asia (17939)
Australia (2106)
California (12270)
Canada (3216)
China (538)
Colorado (490)
Connecticut (424)
Delaware (210)
Europe (24683)
Florida (1839)
Georgia (391)
Hawaii (3)
Idaho (46)
Illinois (719)
India (52)
Indiana (320)
Iowa (16)
Japan (415)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1222)
Massachusetts (8052)
Michigan (312)
Minnesota (568)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (60)
New Jersey (2676)
New Mexico (12)
New York (2876)
North Carolina (1311)
North Dakota (4)
Northern California (6166)
Ohio (288)
Oklahoma (14)
Oregon (18)
Pennsylvania (2289)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5104)
Tennessee (122)
Texas (1989)
United States (39768)
Utah (367)
Vermont (1)
Virginia (157)
Washington D.C. (38)
Washington State (954)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,688 Results for "oyagen inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
OyaGen, Inc. announces a new publication for its COVID therapeutic in development and publication of related patents
OyaGen, Inc. Today the company announced publication in Antiviral Research of studies evaluating the mechanism of action of its proprietary COVID therapeutic in preclinical development.
September 18, 2023
·
3 min read
Pharm Country
Oyagen, Inc. Publishes Study On Its OYA1 As A “Highly Effective” Experimental Drug Candidate For Treating Infections By The Ebola Virus
OyaGen, Inc. announced publication in VIRUSES, a peer reviewed journal, of studies carried out by OyaGen in collaboration with NIH/NIAID Integrated Research Facility at Fort Detrick MD.
January 7, 2021
·
3 min read
Business
OyaGen, Inc. Announces a Compound in Development with Broad Antiviral Activity Against Coronaviruses, including SARS-CoV-2
OyaGen, Inc. announced today new unpublished results from collaborative research with the National Institute of Allergy and Infectious Diseases’ Integrated Research Facility at Fort Detrick, MD
March 11, 2020
·
2 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Business
Tonix Seeks to Advance OyaGen’s COVID-19 Treatment Under New Global Licensing Deal
The companies also plan to develop the candidate for the treatment of other potential future viral diseases.
April 19, 2021
·
3 min read
·
Brandon May
Press Releases
Carlsmed, Inc. Announces Chief Operating Officer Appointment
September 8, 2026
·
2 min read
Press Releases
Glucotrack, Inc. Announces Reverse Stock Split
August 27, 2026
·
6 min read
Press Releases
PostEra’s Fertility programs acquired by EMD Serono, Inc.
September 9, 2026
·
2 min read
Press Releases
argenx Completes Acquisition of Forte Biosciences, Inc.
August 27, 2026
·
6 min read
Press Releases
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
July 29, 2026
·
6 min read
1 of 48,569
Next
